BYOT.L Regulatory News (BYOT)

Byotrol plc

("Byotrol", " or the "Company")

Appointment of Non-Executive Director

Award of Options

Byotrol plc, the AIM listed anti-microbial technology company, is pleased to announce the appointment of Sean Gogarty as a Non-Executive Director of the Company with effect from 29 January 2019.

Sean Gogarty, 53, has a wealth of experience developing and running branded businesses, gained particularly from a 20-year career at Unilever, where his roles included Global CEO Unilever Baking, Cooking and Spreads, and Global Category SVP Household Cleaners. In the latter role, he led the rapid growth of a number of well-known household brands, including Domestos, Cif, Lysoform and Sunlight, from a sales value of E800m to over E2.5bn.

Having started his career in the media sector before moving into industry, Sean also has a strong track record of advising a range of leading PE firms and companies on developing business strategies, brand portfolio plans, organisational structures and supply chain strategies. He also acts as a Non-Executive Director at The Marketing Group plc.

The Company has granted Sean Gogarty options over 2,000,000 shares under the Byotrol plc unapproved share option scheme at a strike price of 2.1p. These options are exercisable in three tranches from 29 January 2020, 2021 and 2022 subject to the Company's share price reaching hurdles of 3p, 5p and 7p.

At the date of this announcement, Mr Gogarty does not have any beneficial interest in the ordinary shares of the Company.

John Langlands, Chairman of the Company, said,

"We are delighted to welcome Sean to the Board of the Byotrol. He has a wealth of experience from his time at Unilever and has a strong record of developing leading global brands and strategies. His considerable experience in both executive and non-executive roles in a wide range of consumer facing businesses will be invaluable to us as we continue to grow and develop Byotrol."

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

Enquiries:

Byotrol plc 01925 742 000

John Langlands - Chairman

David Traynor - Chief Executive

finnCap Ltd 020 7220 0500

Geoff Nash / Kate Bannatyne - Corporate Finance

Richard Chambers - ECM

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to www.byotrol.co.uk

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):